CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 25 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,805 | +28.6% | 33,230 | 0.0% | 0.00% | – |
| Q2 2023 | $48,848 | -25.1% | 33,230 | -0.6% | 0.00% | – |
| Q1 2023 | $65,189 | -24.6% | 33,430 | -13.0% | 0.00% | – |
| Q4 2022 | $86,468 | -20.7% | 38,430 | -15.0% | 0.00% | – |
| Q3 2022 | $109,000 | +1.9% | 45,215 | -12.2% | 0.00% | – |
| Q2 2022 | $107,000 | -57.4% | 51,502 | -42.2% | 0.00% | -100.0% |
| Q1 2022 | $251,000 | -35.1% | 89,083 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $387,000 | +96.4% | 82,920 | +115.5% | 0.00% | 0.0% |
| Q4 2013 | $197,000 | +82.4% | 38,485 | +61.0% | 0.00% | 0.0% |
| Q3 2013 | $108,000 | -16.3% | 23,900 | -5.2% | 0.00% | 0.0% |
| Q2 2013 | $129,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |